1183920--3/8/2006--DADE_BEHRING_HOLDINGS

related topics

{cost, regulation, environmental}

{operation, international, foreign}

{regulation, government, change}

{product, market, service}

{property, intellectual, protect}

{product, candidate, development}

Our failure to compete with other manufacturers in the highly competitive clinical diagnostics industry, some of which have greater financial resources than we do, could harm our ability to retain existing customers and obtain future business. Our profit margins and business approach may be adversely affected by potential healthcare reform. We make significant investments in research and development, but there is no guarantee that any of these investments will ultimately result in a commercial product that will generate revenues. Changes in our business strategy or plans may adversely affect our operating results and financial condition. Because a significant portion of our business is conducted outside the United States, fluctuations in foreign currency exchange rates could adversely affect our results of operations. Our ability to compete depends in part on our ability to protect our intellectual property. We are subject to regulation by various U.S. federal, state and non-U.S. agencies, which requires us to comply with regulations in the design, manufacture and distribution of most of our products and violation of such regulations could adversely affect us. We are subject to various environmental and occupational health and safety laws and any violation of these laws could result in liability that could adversely affect us.

Full 10-K form ▸

1183920--3/8/2006--DADE_BEHRING_HOLDINGS_INC